Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nichols

Showing results (751-760 of 973) with videos related to

Pageof 98
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 4, 2017
Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factorHiroyuki Kanzaki, Alexandru Movila, Rayyan Kayal, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
The Annals of Thoracic Surgery|April 28, 2004
Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resectionMark S Allen, Douglas E Wood, Ronald W Hawkinson, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2013
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancerAnthony C Nichols, David A Palma, Winsion Chow, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Pageof 98

Showing results (751-760 of 973) with videos related to

Sort By:
Pageof 98
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|February 4, 2017
Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factorHiroyuki Kanzaki, Alexandru Movila, Rayyan Kayal, et al.
Blood|January 9, 2010
Prolonged activity of factor IX as a monomeric Fc fusion proteinRobert T Peters, Susan C Low, George D Kamphaus, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2014
Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy InstituteRovel J Colaco, Bradford S Hoppe, Stella Flampouri, et al.
The Annals of Thoracic Surgery|April 28, 2004
Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resectionMark S Allen, Douglas E Wood, Ronald W Hawkinson, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2013
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancerAnthony C Nichols, David A Palma, Winsion Chow, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Pageof 98